C12N2730/00011 - CPC Classification
Classification description:
Reverse transcribing DNA viruses Details
Sub-classes:
- C12N2730/00021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 0
- C12N2730/00022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 8
- C12N2730/00023 » Virus like particles [VLP] 0
- C12N2730/00031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
- C12N2730/00032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 0
- C12N2730/00033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 0
- C12N2730/00034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 0
- C12N2730/00041 » Use of virus, viral particle or viral elements as a vector 2
- C12N2730/00051 » Methods of production or purification of viral material 0
- C12N2730/00061 » Methods of inactivation or attenuation 0
- C12N2730/00071 » Demonstrated in vivo effect 0
- C12N2730/00088 » For redistribution 0
- C12N2730/10011 » Hepadnaviridae 1